[Biguanide--its mechanism of action and indication].
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001645:Biguanides / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000188:drug therapy; D005947:Glucose / Q000378:metabolism; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007700:Kinetics; D010629:Phenformin / Q000494:pharmacology; D010732:Phosphofructokinase-1 / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects
D001645:Biguanides; D001786:Blood Glucose; D007328:Insulin; D000255:Adenosine Triphosphate; D010629:Phenformin; D010732:Phosphofructokinase-1; D005947:Glucose